| ERBB2 Amplification has curated evidence in …HAS_EVIDENCE_INderived15 of 19show all (up to 200) |
|---|
| → has curated evidence in | HER2-Positive Breast Carcinoma 27 accepted items · levels A, B, D · 27 sensitivity / 0 resistance · 24 supports / 3 does not support | sensitivity | A | HER2-Positive Breast Carcinoma | 27 | Curated | civic | graph → |
| → has curated evidence in | Malignant Breast Neoplasm 5 accepted items · levels A, D · 5 sensitivity / 0 resistance · 5 supports / 0 does not support | sensitivity | A | Malignant Breast Neoplasm | 5 | Curated | civic | graph → |
| → has curated evidence in | Gastric Adenocarcinoma 3 accepted items · levels A, B · 3 sensitivity / 0 resistance · 3 supports / 0 does not support | sensitivity | A | Gastric Adenocarcinoma | 3 | Curated | civic | graph → |
| → has curated evidence in | Malignant Colorectal Neoplasm 10 accepted items · levels B, D · 5 sensitivity / 5 resistance · 9 supports / 1 does not support | mixed | B | Malignant Colorectal Neoplasm | 10 | Curated | civic | graph → |
| → has curated evidence in | Lung Non-Small Cell Carcinoma 4 accepted items · levels B, D · 4 sensitivity / 0 resistance · 1 supports / 3 does not support | sensitivity | B | Lung Non-Small Cell Carcinoma | 4 | Curated | civic | graph → |
| → has curated evidence in | Endometrial Serous Adenocarcinomasubtype 2 accepted items · levels B, C · 1 sensitivity / 0 resistance · 2 supports / 0 does not support | sensitivity | B | Endometrial Serous Adenocarcinoma | 2 | Curated | civic | graph → |
| → has curated evidence in | Bladder Carcinoma 1 accepted items · levels B · 1 sensitivity / 0 resistance · 1 supports / 0 does not support | sensitivity | B | Bladder Carcinoma | 1 | Curated | civic | graph → |
| → has curated evidence in | Childhood Ependymoma 1 accepted items · levels B · 1 sensitivity / 0 resistance · 1 supports / 0 does not support | sensitivity | B | Childhood Ependymoma | 1 | Curated | civic | graph → |
| → has curated evidence in | Malignant Biliary Tract Neoplasm 1 accepted items · levels B · 1 sensitivity / 0 resistance · 1 supports / 0 does not support | sensitivity | B | Malignant Biliary Tract Neoplasm | 1 | Curated | civic | graph → |
| → has curated evidence in | Malignant Endometrial Neoplasm 1 accepted items · levels B · 1 sensitivity / 0 resistance · 0 supports / 1 does not support | sensitivity | B | Malignant Endometrial Neoplasm | 1 | Curated | civic | graph → |
| → has curated evidence in | Malignant Gastric Neoplasm 1 accepted items · levels B · 1 sensitivity / 0 resistance · 1 supports / 0 does not support | sensitivity | B | Malignant Gastric Neoplasm | 1 | Curated | civic | graph → |
| → has curated evidence in | Malignant Pancreatic Neoplasm 1 accepted items · levels B · 1 sensitivity / 0 resistance · 1 supports / 0 does not support | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| → has curated evidence in | Malignant Uterine Neoplasm 1 accepted items · levels B · 1 sensitivity / 0 resistance · 0 supports / 1 does not support | sensitivity | B | Malignant Uterine Neoplasm | 1 | Curated | civic | graph → |
| → has curated evidence in | Salivary Gland Carcinoma 1 accepted items · levels B · 1 sensitivity / 0 resistance · 1 supports / 0 does not support | sensitivity | B | Salivary Gland Carcinoma | 1 | Curated | civic | graph → |
| → has curated evidence in | Cholangiocarcinoma 1 accepted items · levels C · 1 sensitivity / 0 resistance · 1 supports / 0 does not support | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |